The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The approval bolsters the company's Mycophenolate Mofetil portfolio
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Marks the World Head & Neck Cancer Day at the OCTF Conference
Uses a simple mechanical approach for removing intrauterine tissues
Subscribe To Our Newsletter & Stay Updated